• Medientyp: E-Artikel
  • Titel: Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential
  • Beteiligte: Azmatullah, Syed; Khan, Arif-ullah; Qazi, Neelam Gul; Nadeem, Humaira; Irshad, Nadeem
  • Erschienen: Springer Science and Business Media LLC, 2022
  • Erschienen in: BMC Pharmacology and Toxicology, 23 (2022) 1
  • Sprache: Englisch
  • DOI: 10.1186/s40360-022-00596-0
  • ISSN: 2050-6511
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: AbstractThe present study aims to investigate the newly synthesized organotin (IV) complex (2E, 2′E) dibutylstannanediyl bis (4-(4-nitrophenyl) amino)-4-oxobut-2-enoate (DTN) for its anti-ulcer potential. Characterization performed by carbon nuclear magnetic resonance spectroscopy proved that all values are in the expected ranges of the new compound. Gastroprotective activity of DTN was evaluated throughin-silico,anti-H. pylori,in-vitro,in-vivo, and ex-vivo proteomic analysis.In-silicoanalysis shows that DTN possess stable binding with protein targets involved in gastric ulcer pathophysiology. DTN exhibited an inhibitory effect against 2,2-diphenyl-1-picrylhydrazyl,H. pyloriand hydrogen potassium ATPase (H+/K+-ATPase). The antiulcer activity was performed using an ethanol-induced gastric ulcer model in rats. Anti-oxidant profile of DTN showed a significant increase in glutathione-S-transferase, glutathione and catalase levels whereas lipid peroxidation levels were reduced. Histopathological findings confirmed that DTN protected the gastric mucosa of rats. Inflammatory markers tumor necrosis factor-alpha, nuclear factor kappa B, cyclooxygenase-2, interleukin 6 and interleukin-1β were reduced and prostaglandin-E2restored expression of these cytokines in DTN pretreated animals when analyzed by using immunohistochemistry, enzyme-linked immunosorbent assay and western blot techniques. In real-time polymerase chain reaction technique, the expression of H+/K+-ATPase was downregulated in DTN pretreated group. DTN did not cause any mortality up to 400 mg/Kg. This study indicates that the newly synthesized compound DTN, possess stable binding against selected targets. DTN exhibits a gastro-protective effect, mediated via anti-H. pylori,H+/K+-ATPase inhibition, anti-oxidant and anti-inflammatory pathways, exploring its therapeutic potential in gastric ulcer management.
  • Zugangsstatus: Freier Zugang